← All organizations

XBiotech, Inc.

For profitWebsite ↗

Also known as: XBiotech, Inc. | XBiotech USA, Inc.

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Last known activity

Sep 15, 2024

Timeline

2000s

Jan 1, 2007
XBiotech, Inc.— Founded

Drugs by trial phase (7 distinct, 22 trials)

Phase 3 (1 own, 0 via acquisition)

xilonix

Phase 2 (5 own, 0 via acquisition)

Phase 1 (1 own, 0 via acquisition)

hutrukin

Indications

Studied for

Recent trials (24)

NCT06590090Lead sponsorPhase 2Sep 15, 2024
NCT06526377Lead sponsorPhase 2Aug 15, 2024
NCT05363891Lead sponsorPhase 2Jun 15, 2022
NCT05363917Lead sponsorPhase 2Jun 15, 2022
NCT05099510Lead sponsorPhase 1Nov 22, 2021
NCT05098080Lead sponsorPhase 1Nov 15, 2021
NCT04021862Lead sponsorPhase 2Nov 30, 2019
NCT04019041Lead sponsorPhase 2Sep 30, 2019
NCT03512275Lead sponsorPhase 2Jun 20, 2018
NCT03496974Lead sponsorPhase 2May 21, 2018
NCT03207724CollaboratorPhase 1Oct 16, 2017
NCT03047317Study directorPhase 1Feb 15, 2017
NCT03047317Lead sponsorPhase 1Feb 15, 2017
NCT02357966Lead sponsorPhase 1/Phase 2May 1, 2015
NCT02138422Lead sponsorPhase 3Jul 1, 2014

Details

Founded: Austin, TX, US Jan 1, 2007
Last known activity: Sep 15, 2024